Flight Attendants Have Higher Rates of Many Cancers, Study Says
Flight attendants are exposed to a number of known cancer-causing risks, but few studies have rigorously quantified that risk, and researchers say they are an understudied occupational group.
The Harvard Flight Attendant Health Study (FAHS), begun in 2007, addresses some of the gaps in understanding health risks among flight attendants. In the latest report, published in the journal Environmental Health, researchers found that flight attendants had higher rates of many cancers, including breast cancer and melanoma, compared to the general population.
The FAHS included more than 5,300 flight attendants who were recruited th...
Source: TIME: Health - June 26, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news
Women With DCIS Who Are at Low Risk for Recurrence Identified Women With DCIS Who Are at Low Risk for Recurrence Identified
Women with ductal carcinoma in situ (DCIS) who are at low risk for disease recurrence after conservative breast surgery and radiotherapy, and whose treatment could be reduced, have been identified.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Managing Ductal Carcinoma In Situ in the Era of Genomic Profiling
At the 2018 Miami Breast Cancer Conference, Dr. Patrick Borgen presented information related to gene expression profiling as a tool for managing DCIS. (Source: CancerNetwork)
Source: CancerNetwork - March 20, 2018 Category: Cancer & Oncology Authors: Patrick I. Borgen, MD Tags: Breast Cancer Conference Report Conferences/MBCC Source Type: news
Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial
This research article has led to a Practice Changing Update in DynaMed Plus. It concludes that radioactive seed localization may have similar positive margin but higher successful placement rates compared to wire localization in women having breast-conserving surgery for nonpalpable invasive breast cancer or ductal carcinoma in situ (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 18, 2018 Category: Consumer Health News Source Type: news
New cancer model shows genomic link between early-stage and invasive breast cancer types
(University of Texas M. D. Anderson Cancer Center) A new genetic-based model may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ (DCIS) progresses to a more invasive form of cancer say researchers at The University of Texas MD Anderson Cancer Center. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 4, 2018 Category: Biology Source Type: news
Case: Metastatic Endometrial Serous Carcinoma to the Breast Case: Metastatic Endometrial Serous Carcinoma to the Breast
This unusual case underscores that while the breast is an atypical target of metastases, it is a possibility that needs to be considered, and should be confirmed histologically.Applied Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 11, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Primary Small Cell Carcinoma of the Breast: A Case Report Primary Small Cell Carcinoma of the Breast: A Case Report
This case report sheds light on small cell carcinoma of the breast, a rarely described subtype of neuroendocrine breast cancer, providing a comprehensive approach to diagnosis and management.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 30, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
NAFLD Linked to Increased Cancer Incidence Rate
NAFLD strongly tied to development of hepatocellular carcinoma, CRC in males, breast cancer in females (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 20, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Radiology, Journal, Source Type: news
Nonalcoholic fatty liver disease increases risk of liver, colorectal, and breast cancers
(Elsevier) Nonalcoholic fatty liver disease (NAFLD) is one of the more common chronic liver diseases worldwide. It is associated with metabolic syndrome (i.e. insulin resistance and diabetes) and predisposes to cardiovascular disease. In a new study published in the Journal of Hepatology, researchers identified links not only between NAFLD and hepatocellular carcinoma (HCC), which have been well established, but also to cancers outside the liver, including colorectal and breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2017 Category: Cancer & Oncology Source Type: news
Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
First Avastin® (Bevacizumab) Biosimilar Candidate Recommended for European Approval
THOUSAND OAKS, Calif., Nov. 10, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc. (NYSE:AGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing Authorization of ABP 215, a biosimilar to Avastin® (bevacizumab). ABP 215 has been recommended for approval for the treatment of certain types of cancer, including in combination with fluoropyrimidine-based chemotherapy for metastatic carcinoma of the colon or rectum; i...
Source: Amgen News Release - November 10, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news
Sharing Mayo Clinic: Breast cancer patient finds answer in centralized care
Renee Hill had received opinions from other health care facilities but desperately wanted to have her medical care centralized and coordinated. "My gut was telling me Mayo was where I needed to go," she says.? When Renee Hill was diagnosed with breast cancer ? stage 3 invasive ductal carcinoma ? on her birthday in July [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 22, 2017 Category: Databases & Libraries Source Type: news
New drug successful to treat drug-resistant thyroid cancer
According to a study published inOncotarget, palbociclib, normally used in the treatment of breast cancer, can be used to treat papillary thyroid carcinomas that are resistant to vemurafenib.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 19, 2017 Category: Endocrinology Source Type: news
Unrelenting NHS pressure affecting cancer care, say GPs and nurses
Half of GPs and primary care nurses not confident NHS workforce can provide adequate care Related items fromOnMedica Nasopharyngeal carcinoma and sinus cancer UK spends 20% less on cancer treatment than rest of EU Fifteen local NHS transformation projects to get cash boost The genetics of breast cancer Meeting cancer promises and more – a new model for NHS diagnostics? (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 8, 2017 Category: UK Health Source Type: news
Rare Neuroendocrine Breast Cancer Not So Unusual Rare Neuroendocrine Breast Cancer Not So Unusual
Neuroendocrine breast cancer can be indistinguishable from high-grade ductal carcinoma, although treatment is different, and can be missed unless stained specifically for neuroendocrine markers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 7, 2017 Category: Consumer Health News Tags: Pathology & Lab Medicine News Source Type: news
